| Literature DB >> 19644570 |
Venkata R Narala1, Monica R Smith, Ravi K Adapala, Rajesh Ranga, Kalpana Panati, Bethany B Moore, Todd Leff, Vudem D Reddy, Anand K Kondapi, Raju C Reddy.
Abstract
Curcumin, a compound found in the spice turmeric, has been shown to possess a number of beneficial biological activities exerted through a variety of different mechanisms. Some curcumin effects have been reported to involve activation of the nuclear transcription factor peroxisome proliferator-activated receptor-γ (PPAR-γ), but the concept that curcumin might be a PPAR-γ ligand remains controversial. Results reported here demonstrate that, in contrast to the PPAR-γ ligands ciglitazone and rosiglitazone, curcumin is inactive in five different reporter or DNA-binding assays, does not displace [(3)H]rosiglitazone from the PPAR-γ ligand-binding site, and does not induce PPAR-γ-dependent differentiation of preadipocytes, while its ability to inhibit fibroblast-to-myofibroblast differentiation is not affected by any of four PPAR-γ antagonists. These multiple lines of evidence conclusively demonstrate that curcumin is not a PPAR-γ ligand and indicate the need for further investigation of the mechanisms through which the compound acts.Entities:
Year: 2009 PMID: 19644570 PMCID: PMC2717748
Source DB: PubMed Journal: Gene Ther Mol Biol ISSN: 1529-9120